Automating Patient Follow-Ups Without Breaking DPDP or NMC Rules

The moment a clinic automates anything involving patient contact details, it stops being purely an operations question and becomes a legal one. Two frameworks apply directly, and both carry real consequences for getting it wrong — not theoretical ones.

DPDP Act 2023 — what actually changes

India’s Digital Personal Data Protection Act 2023 treats a patient’s phone number, appointment history, and any linked health information as personal data requiring lawful handling. For a clinic running automated follow-ups, three obligations matter in practice:

• Consent has to be specific and recorded. A patient providing their number to book an appointment is not automatically consent to receive ongoing automated messages — that needs to be asked for separately and logged.
• Purpose limitation applies. Data collected for appointment reminders shouldn’t quietly get reused for unrelated marketing without fresh consent.
• Security is the clinic’s responsibility, not just the vendor’s. If patient data sits in an automation platform, the clinic needs to know how it’s stored, who can access it, and what happens to it if the vendor relationship ends.

NMC / IMC Code of Ethics — where automated messaging can cross a line

The National Medical Commission’s advertising rules (built on the earlier IMC Code of Ethics 2002) restrict solicitation, testimonials, and anything that reads as an inducement to seek treatment. A follow-up message reminding a patient of a genuinely due check-up is legitimate clinical continuity. The same message reworded to push an unnecessary procedure, or offering a discount to “come back,” crosses directly into solicitation — a real ethics violation, not a grey area.

The safe test: would this message exist if the clinic weren’t trying to generate a visit? A genuine follow-up reminder passes. A disguised sales pitch doesn’t.

The practical checklist

• Consent captured and stored before any patient enters an automated messaging flow.
• A clear, easy opt-out on every message.
• No pricing, discounts, or “book now” urgency language in clinical follow-up messages.
• A written record of where patient data lives and who can access it.
• Every message template reviewed against IMC/NMC advertising rules before it’s approved and sent.

Why this is worth doing properly, not just quickly

The efficiency gains from automation are real, but they’re not worth a DPDP penalty or an NMC complaint. Building the compliance layer in from the start costs a small amount of extra setup time. Retrofitting it after a complaint costs far more — in money, in a doctor’s licence standing, and in the trust of every patient whose data was mishandled.